Pannexin-1 promotes CD8+ T cell antitumor immunity against colorectal cancer in a gender-dependent way 2256739
Findings suggest PANX1 promotes CD8+T cell-driven anti-tumor immunity in CRC in a gender-dependent manner, potentially explaining sex-based differences.